Internal Medicine, Hematology & Oncology · Westwood, KS
NPI
1093971277
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2330 Shawnee Mission Pkwy, Suite 210
Westwood, KS, 66205
Phone (913) 588-6030
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,374 services
Medicare patients, 2024
202
Average age 68
Drug cost, 2024
$969K
1,193 prescriptions
Company payments, 2025
$246
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anurag K Singh was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 376 times for 116 patients. In total Anurag K Singh billed 1,374 services in 18 codes, and Medicare paid $95K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 376 | 116 | $12.68 | $4,768 |
| 99233 Hospital E&M - Subsequent | Facility | 331 | 73 | $90.45 | $30K |
| 99214 Office E&M - Established | Office | 282 | 99 | $74.81 | $21K |
| 99215 Office E&M - Established | Office | 219 | 85 | $110.22 | $24K |
| 99223 Hospital E&M - Initial | Facility | 40 | 38 | $127.07 | $5,083 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 34 | 22 | $24.01 | $816 |
| 99239 Hospital Discharge Management | Facility | 24 | 23 | $87.87 | $2,109 |
| 99238 Hospital Discharge Management | Facility | 17 | 15 | $62.36 | $1,060 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 15 | 13 | $146.59 | $2,199 |
| 99205 Office E&M - New | Office | 12 | 12 | $138.68 | $1,664 |
By year: 2022 $80K for 1,000 services; 2023 $79K for 904 services; 2024 $95K for 1,374 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anurag K Singh prescribed most often to Medicare patients was Acyclovir, with 159 prescriptions and refills. In total Anurag K Singh wrote 1,193 Medicare prescriptions that cost $969K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 159 | 216 | 53 | $3,716 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 107 | 136 | 26 | $842 |
| Pantoprazole Sodium Generic | 46 | 104 | 18 | $505 |
| Levothyroxine Sodium Generic | 38 | 84 | 12 | $480 |
| Pentacel Dipht,pert(A),tet-Polio/Hib/Pf | 37 | 37 | 23 | $3,971 |
| Posaconazole Generic | 34 | 34 | Under 11 | $32K |
| Valacyclovir Valacyclovir Hcl | 27 | 29 | Under 11 | $1,264 |
| Levofloxacin Generic | 27 | 27 | 18 | $288 |
| Amlodipine Besylate Generic | 27 | 63 | 11 | $196 |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 26 | 26 | 22 | $4,818 |
| Menveo A-C-Y-W-135-Dip Mening Vac A,c,y,w-135 Dip/Pf | 25 | 25 | 18 | $4,010 |
| Montelukast Sodium Generic | 23 | 52 | Under 11 | $272 |
| Jakafi Ruxolitinib Phosphate | 22 | 22 | Under 11 | $315K |
| Prochlorperazine Maleate Generic | 21 | 21 | 19 | $324 |
| Gabapentin Generic | 21 | 27 | Under 11 | $334 |
Brand drugs: - claims; generic drugs: 941 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anurag K Singh $246 ($246 in general payments such as food, travel and fees) from 2 companies. The largest payer was Genmab U.S., Inc. with $124.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.